Technical Analysis for EDSA - Edesa Biotech, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 4.55 | 0.66% | 0.03 |
EDSA closed up 0.66 percent on Wednesday, May 8, 2024, on 67 percent of normal volume. It was able to find support at its 50 day moving average. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 0.00% | |
| 50 DMA Support | Bullish | 0.00% | |
| Hammer Candlestick | Bullish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Reversed from Down | about 11 hours ago |
| 20 DMA Support | about 11 hours ago |
| 10 DMA Support | about 11 hours ago |
| 50 DMA Support | about 11 hours ago |
| Down 5% | about 12 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on efficiently developing innovative treatments that address significant unmet medical needs. Edesa's lead product candidate, EB01, is a novel non-steroidal anti-inflammatory molecule (sPLA2 inhibitor) for the treatment of chronic allergic contact dermatitis which has demonstrated statistically significant improvements in multiple clinical studies. Edesa also intends to expand the utility of its sPLA2 inhibitor technology, which forms the basis for EB01, across multiple indications. The company is based in Toronto, Canada, with U.S. offices in Southern California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Medication Dermatitis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Medication Dermatitis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.3331 |
| 52 Week Low | 0.3927 |
| Average Volume | 7,746 |
| 200-Day Moving Average | 3.32 |
| 50-Day Moving Average | 4.44 |
| 20-Day Moving Average | 4.44 |
| 10-Day Moving Average | 4.49 |
| Average True Range | 0.30 |
| RSI (14) | 53.05 |
| ADX | 24.72 |
| +DI | 25.26 |
| -DI | 17.52 |
| Chandelier Exit (Long, 3 ATRs) | 3.99 |
| Chandelier Exit (Short, 3 ATRs) | 5.03 |
| Upper Bollinger Bands | 4.63 |
| Lower Bollinger Band | 4.24 |
| Percent B (%b) | 0.79 |
| BandWidth | 8.93 |
| MACD Line | 0.02 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0181 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.20 | ||||
| Resistance 3 (R3) | 5.12 | 4.84 | 5.09 | ||
| Resistance 2 (R2) | 4.84 | 4.67 | 4.87 | 5.05 | |
| Resistance 1 (R1) | 4.69 | 4.57 | 4.77 | 4.77 | 5.02 |
| Pivot Point | 4.41 | 4.41 | 4.44 | 4.44 | 4.41 |
| Support 1 (S1) | 4.26 | 4.24 | 4.34 | 4.34 | 4.08 |
| Support 2 (S2) | 3.98 | 4.14 | 4.01 | 4.05 | |
| Support 3 (S3) | 3.83 | 3.98 | 4.01 | ||
| Support 4 (S4) | 3.91 |
